{"id":2596,"date":"2019-08-04T21:00:13","date_gmt":"2019-08-04T18:00:13","guid":{"rendered":"http:\/\/blog.ulubat.org\/?p=2596"},"modified":"2019-08-17T23:07:24","modified_gmt":"2019-08-17T20:07:24","slug":"antidepresanlarin-tedavide-yeri-ve-gercek-yan-etkileri","status":"publish","type":"post","link":"https:\/\/blog.ulubat.org\/index.php\/genel\/antidepresanlarin-tedavide-yeri-ve-gercek-yan-etkileri\/","title":{"rendered":"ANT\u0130DEPRESANLARIN TEDAV\u0130DE YER\u0130 VE GER\u00c7EK YAN ETK\u0130LER\u0130"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

Klinik olarak tan\u0131m\u0131 ilk kez 1950’lerde yap\u0131lan ve 1980’lerin sonuna do\u011fru t\u00fcm d\u00fcnyada yayg\u0131nla\u015fan Antidepresan, ba\u015fta “Maj\u00f6r Depresif Bozukluk” ve “Anksiyete Bozukluklar\u0131” gibi psikiyatrik bozukluklar\u0131 tedavi edebilmek ya da en az\u0131ndan semptomlar\u0131n\u0131 hafifletmek i\u00e7in tercih edilen bir ila\u00e7 grubudur. Antidepresan kullan\u0131m\u0131yla, mod ve davran\u0131\u015fta de\u011fi\u015fikli\u011fe sebep oldu\u011fu d\u00fc\u015f\u00fcn\u00fclen n\u00f6rotransmitterlerin orans\u0131zl\u0131\u011f\u0131 d\u00fczeltilmesi ama\u00e7lan\u0131r.<\/p><\/blockquote>\n\n\n\n

<\/p>\n\n\n\n

Amerikan Psikiyatri Birli\u011fi’nin a\u00e7\u0131klamas\u0131na g\u00f6re Antidepresan, depresyonu tedavi etmek i\u00e7in \u00e7o\u011fu psikiyatristin ba\u015fvurdu\u011fu ilk se\u00e7enektir. D\u00fcnyada bu kadar yayg\u0131nla\u015fan bir ila\u00e7 grubuna kar\u015f\u0131t g\u00f6r\u00fc\u015fler belirten ve kullan\u0131m\u0131n\u0131 katiyen reddeden bir kesim muhakkak ki mevcut. Bu iki kesim aras\u0131ndaki g\u00f6r\u00fc\u015f farkl\u0131l\u0131\u011f\u0131 o kadar iki ayr\u0131 noktada ki, bir kesim antidepresanlar\u0131n hayat kurtar\u0131c\u0131 oldu\u011funu savunurken, di\u011fer kesim tedaviye hi\u00e7bir katk\u0131s\u0131 olmad\u0131\u011f\u0131n\u0131 hatta ba\u011f\u0131ml\u0131l\u0131k yapt\u0131\u011f\u0131n\u0131 savunur.<\/p>\n\n\n\n

Peki hangi taraf\u0131 dinlemeliyiz? E\u011fer psikiyatrik bir sorunla kar\u015f\u0131 kar\u015f\u0131yaysak antidepresanlar\u0131 kullanmal\u0131y\u0131 m\u0131y\u0131z? Yoksa antidepresanlar\u0131 rafa kald\u0131r\u0131p ba\u015fka y\u00f6ntemler mi bulmal\u0131y\u0131z? E\u011fer kullanacaksak Antidepresanlar\u0131n yan etkileri ger\u00e7ekten de nedir? Antidepresanlar\u0131n getirisinden \u00e7ok g\u00f6t\u00fcr\u00fcs\u00fc m\u00fc var ?\u0130ntihara s\u00fcr\u00fckler mi? <\/p>\n\n\n\n

Bu sorular\u0131n cevab\u0131n\u0131 bulmaya \u00e7al\u0131\u015f\u0131rken internette fazlaca yalan yanl\u0131\u015f bilginin oldu\u011funu da fark ettim. Bu y\u00fczden do\u011fru bilgileri ve kar\u015f\u0131t g\u00f6r\u00fc\u015fleri en do\u011fru \u015fekilde bulup , harmanlay\u0131p size sunmaya karar verdim. \u015eimdiden iyi okumalar \ud83d\ude42<\/p>\n\n\n\n

<\/p>\n\n\n\n

Antidepresan Nedir? Ni\u00e7in Kullan\u0131l\u0131r?<\/strong><\/p>\n\n\n\n

<\/p>\n\n\n\n

Antidepresan, beyindeki n\u00f6rotransmitterlerin kimyasal dengesizli\u011fini d\u00fczelterek depresif bozukluklar\u0131n semptomlar\u0131n\u0131 hafifleten bir ila\u00e7 grubudur. Beyindeki kimyasal dengesizlikler ruh hali ve davran\u0131\u015f de\u011fi\u015fikli\u011fine sebep olabilir.<\/p>\n\n\n\n


Antidepresanlar, depresyon, genel anksiyete bozuklu\u011fu, obsesif komp\u00fclsif bozukluk, manik-depresif bozukluk, maj\u00f6r-depresif bozukluk, diyabetik periferal n\u00f6ropatik a\u011fr\u0131, n\u00f6ropatik a\u011fr\u0131, sosyal anksiyete bozuklu\u011fu, postravmatik stres bozuklu\u011funu tedavi i\u00e7in kullan\u0131l\u0131r.<\/p>\n\n\n\n


Antidepresanlar ayn\u0131 zamanda endikasyon d\u0131\u015f\u0131 da kullan\u0131l\u0131r. Antidepresanlar\u0131n endikasyon d\u0131\u015f\u0131 hangi bozukluklarda kullan\u0131ld\u0131\u011f\u0131n\u0131 a\u00e7\u0131klamadan \u00f6nce endikasyon d\u0131\u015f\u0131 ila\u00e7 kullan\u0131m\u0131n\u0131 a\u00e7\u0131klamam gerekiyor. <\/p>\n\n\n\n

Endikasyon d\u0131\u015f\u0131 ila\u00e7 kullan\u0131m\u0131, ilac\u0131n, ruhsat\u0131nda belirtilen kullan\u0131m alanlar\u0131 ve\/veya kullan\u0131m \u015fartlar\u0131 (doz, s\u00fcre gibi) d\u0131\u015f\u0131nda kullan\u0131lmas\u0131d\u0131r. <\/p> https:\/\/dergipark.org.tr\/download\/article-file\/315255
<\/cite><\/blockquote>\n\n\n\n

Antidepresanlar\u0131n Endikasyon d\u0131\u015f\u0131 kullan\u0131ld\u0131\u011f\u0131 alanlar, fibromiyalji, kurde\u015fen, ate\u015f basmas\u0131, ka\u015f\u0131nt\u0131, premenstr\u00fcel semptomlar, bulimia nervoza ve Tourette Sendromu’dur.<\/p>\n\n\n\n

<\/p>\n\n\n\n

Antidepresan \u00c7al\u0131\u015fma Mekanizmas\u0131<\/strong><\/p>\n\n\n\n

<\/p>\n\n\n\n

Antidepresanlar\u0131n tam olarak nas\u0131l \u00e7al\u0131\u015ft\u0131\u011f\u0131 hala bilinmese de, beyindeki n\u00f6rotransmitterlerin seviyesini y\u00fckselterek \u00e7al\u0131\u015ft\u0131\u011f\u0131 d\u00fc\u015f\u00fcn\u00fcl\u00fcyor. Antidepresanlar\u0131n n\u00f6rotransmitterlerin seviyesini nas\u0131l y\u00fckseltti\u011fi birka\u00e7 teoriyle a\u00e7\u0131klansa da, en yayg\u0131n, en kabul g\u00f6ren teoriyi size a\u00e7\u0131klayay\u0131m.<\/p>\n\n\n\n

<\/p>\n\n\n\n

\"\"

https:\/\/www.drugabuse.gov\/news-events\/nida-notes\/2017\/03\/impacts-drugs-neurotransmission<\/a> <\/figcaption><\/figure><\/div>\n\n\n\n

sinir h\u00fccresi aras\u0131ndaki ileti\u015fim n\u00f6rotransmitterlerle sa\u011flan\u0131r. N\u00f6rotransmitterler sal\u0131nan ve al\u0131nan sinir h\u00fccrelerinin vezik\u00fcllerinde bulunur. Al\u0131c\u0131 sinir h\u00fccreleri, n\u00f6rotransmitterleri almazsa, n\u00f6rotransmitterleri serbest b\u0131rakan sinir h\u00fccreleri taraf\u0131ndan geri al\u0131n\u0131r. Bu s\u00fcre\u00e7 “Geri Al\u0131m” olarak adland\u0131r\u0131l\u0131r. Depresyona spesifik olan n\u00f6rotransmitterler “Serotonin, Dopamin, Norepinefrin”dir. <\/p>\n\n\n\n

<\/p>\n\n\n\n

Antidepresan Tipleri Ve Spesifik Yan Etkileri<\/strong><\/p>\n\n\n\n

\u00c7o\u011fu antidepresan tipi, dopamin, serotonin, norepinefrin n\u00f6rotransmitterlerine etki ederek semptomlar\u0131 hafifletir. Fakat antidepresan tiplerinin n\u00f6rotransmitterlere etki \u015fekli birbirinden olduk\u00e7a farkl\u0131d\u0131r.<\/p>\n\n\n\n


D\u00fcnyada en yayg\u0131n kullan\u0131lan antidepresanlar, “Trisiklik Antidepresanlar”, “Se\u00e7ici Serotonin Geri-al\u0131m \u0130nhibit\u00f6rleri (SSRI)” ve “Se\u00e7ici Serotonin Noradrenalin Geri-al\u0131m \u0130nhibit\u00f6rleri (SSNRI)”dir. <\/p>\n\n\n\n


Trisiklik antidepresanlar en eski antidepresan tipidir ve bu y\u00fczden 1. nesil antidepresan olarak adland\u0131r\u0131l\u0131r. SSRI ve SNRI ise 2. nesil antidepresanlard\u0131r. Bunlar\u0131n d\u0131\u015f\u0131nda “Monoamin Oksidaz \u0130nhibit\u00f6rleri” de antidepresan tipleri aras\u0131ndad\u0131r.<\/p>\n\n\n\n

1. Trisiklik Antidepresanlar
Kimyasal yap\u0131s\u0131nda \u00fc\u00e7 halka bulundu\u011fu i\u00e7in “Trisiklik Antidepresanlar” olarak adland\u0131r\u0131lan bu ila\u00e7 grubu ise, fibromiyalji, anksiyete ve kronik a\u011fr\u0131lar\u0131 tedavi etmek i\u00e7in kullan\u0131l\u0131r.
Trisiklik Antidepresanlar\u0131n yan etkilerinin aras\u0131nda,
I. Epilepsi,
II. Insomnia,
III. Anksiyete,
IV. Aritmi,
V. Hipertansiyon,
VI. Mide bulant\u0131s\u0131 ve kusma,
VII. Kilo kayb\u0131,
VIII. Kab\u0131zl\u0131k,
IX. G\u00f6z bas\u0131nc\u0131n\u0131n y\u00fckselmesi,
X. \u0130drar retansiyonu vard\u0131r.<\/p>\n\n\n\n

2.SSRI ve SNRI
Doktorlar\u0131n en \u00e7ok tercih etti\u011fi antidepresan olan SSRI depresyonda etkili oldu\u011fu kadar, di\u011fer antidepresanlara oranla \u00e7ok daha yan etkiye sahiptir. SSRI, serotoninin geri al\u0131m\u0131n\u0131 inhibe eder ve b\u00f6ylece ruh halinde stabiliteyi sa\u011flar. SNRI ise, beyinde ruh halini stabil olmas\u0131nda kilit rol oynayan n\u00f6rotransmitterler olan “Norepinefrin” ve “Serotonin” seviyesini y\u00fckseltir.SNRI’n\u0131n depresyonu tedavi etmesinin yan\u0131 s\u0131ra, hiperaktivitede de etkili oldu\u011fu bilinmektedir. <\/code><\/p>\n\n\n\n

SSRI ve SNRI ila\u00e7 gruplar\u0131n\u0131n olas\u0131 yan etkileri ise:<\/code> <\/p>\n\n\n\n

I. Hipoglisemi
II. Sodyum d\u00fc\u015f\u00fckl\u00fc\u011f\u00fc
III. Mide bulant\u0131s\u0131
IV. Ka\u015f\u0131nt\u0131
V. A\u011f\u0131z kurulu\u011fu
VI. Diyare veya Kab\u0131zl\u0131k
VII. Kilo Kayb\u0131
VIII. Terleme
IX. Titreme
X. Insomnia
XI. Ba\u015f a\u011fr\u0131s\u0131
XII. Anksiyete
<\/p>\n\n\n\n

3. Monoamin Oksidaz \u0130nhibit\u00f6rler
SSRI ve SNRI tipi antidepresanlardan \u00f6nce kullan\u0131lan “Monoamin Oksidaz \u0130nhibit\u00f6rleri” ise, beyindeki serotonini par\u00e7alayan monoamin oksidaz enzimini inhibe eder ve b\u00f6ylece serotoninin par\u00e7alanmas\u0131n\u0131n \u00f6nler ve sirk\u00fcle olan serotonin seviyesinin y\u00fcksek kalmas\u0131n\u0131 sa\u011flar.
Monoamin Oksidaz \u0130nhibit\u00f6rlerinin yan etkileri ise \u015funlard\u0131r:
I. Bulan\u0131k G\u00f6rme
II. \u00d6dem
III. Epilepsi
IV. Diyare, mide bulant\u0131s\u0131, kab\u0131zl\u0131k
V. Insomnia
VI. Ba\u015f a\u011fr\u0131s\u0131
VII. Anksiyete
VIII. Aritmi
IX. Hipertansiyon
X. Ba\u015f d\u00f6nmesi<\/p>\n\n\n\n

<\/p>\n\n\n\n

Antidepresan Se\u00e7imi Nas\u0131l Yap\u0131l\u0131r? Hangi Fakt\u00f6rler G\u00f6z \u00d6n\u00fcne Al\u0131nmal\u0131d\u0131r?<\/strong><\/p>\n\n\n\n

Bir doktor hastay\u0131 tedavi ederken antidepresan kullan\u0131m\u0131n\u0131 uygun g\u00f6rd\u00fc\u011f\u00fc zaman g\u00f6z \u00f6n\u00fcnde bulundurdu\u011fu birtak\u0131m fakt\u00f6rler vard\u0131r. Bu fakt\u00f6rlerin hepsi hastan\u0131n kimli\u011fini ortaya \u00e7\u0131karan ve hastan\u0131n en iy \u015fekilde tedavi olmas\u0131n\u0131 sa\u011flayan fakt\u00f6rlerdir. Bu fakt\u00f6rler de\u011ferlendirilip ila\u00e7 tedavisine ba\u015fland\u0131\u011f\u0131nda, her zaman ayn\u0131 ilaca devam edilecek diye bir kaide yoktur. Bazen bir hasta i\u00e7in do\u011fru ilac\u0131 bulmak zaman alabilir ve hasta birka\u00e7 kere ilac\u0131n\u0131n de\u011fi\u015ftirmek zorunda kalabilir.
Peki nedir g\u00f6z \u00f6n\u00fcne al\u0131nan fakt\u00f6rler?
i. Hastan\u0131n ge\u00e7irdi\u011fi depresyonun semptomlar\u0131
ii. Antidepresanlar\u0131n olas\u0131 yan etkileri
iii. Kullan\u0131lacak ilac\u0131n\/ila\u00e7lar\u0131n yak\u0131n akrabada nas\u0131l etkiler b\u0131rakt\u0131\u011f\u0131
iv. Antidepresanlar\u0131n di\u011fer ila\u00e7larla etkile\u015fimi
v. Hamilelik ve Emzirme
vi. Olas\u0131 di\u011fer sa\u011fl\u0131k sorunlar\u0131
vii. Maddi durum<\/p>\n\n\n\n

Antidepresan Tedavide Ne Kadar Etkili?<\/strong><\/p>\n\n\n\n

\"\"
The Lancet Journal<\/figcaption><\/figure><\/div>\n\n\n\n

2018 y\u0131l\u0131n\u0131n \u015fubat ay\u0131nda “Lancet” dergisi antidepresanlarla ilgili bir \u00e7al\u0131\u015fma yay\u0131nlad\u0131. \u00c7al\u0131\u015fma antidepresanlar\u0131n ne kadar etkili oldu\u011funu sorguluyordu ve bu \u00e7al\u0131\u015fmaya g\u00f6re bir ilac\u0131n etkili olarak kabul edilmesi i\u00e7in semptomlar\u0131n en az %50 oran\u0131nda azaltmas\u0131 gerekti\u011fi kabul edildi ve \u00e7al\u0131\u015fmada antidepresanlar depresyonun semptomlar\u0131n\u0131 hafifletmekte plasebo ila\u00e7lara oranla daha etkili oldu\u011fu tespit edildi. <\/p>\n\n\n\n


Bu \u00e7al\u0131\u015fmada ayn\u0131 zamanda antidepresanlar aras\u0131ndaki etkililik oranlar\u0131 da k\u0131yasland\u0131 ve her ilac\u0131n ayn\u0131 oranda etkili olmad\u0131\u011f\u0131, baz\u0131 ila\u00e7lar\u0131n etkisinin daha y\u00fcksek oldu\u011fu tespit edildi.<\/p>\n\n\n\n

<\/p>\n\n\n\n

Antidepresan\u0131n Etkisini G\u00f6rebilmek \u0130\u00e7in Ne Kadar S\u00fcre Kullanmak Gerekir? <\/strong><\/p>\n\n\n\n

Antidepresan\u0131 ne kadar kullan\u0131lmas\u0131 gerekti\u011fi ki\u015finin hangi psikiyatrik bozukluktan veya hastal\u0131ktan tedavi edildi\u011fine ba\u011fl\u0131d\u0131r.<\/p>\n\n\n\n


E\u011fer depresyon i\u00e7in antidepresan kullanan biri iseniz, antidepresan\u0131n olumlu etkilerini g\u00f6rmeniz 2 ile 4 hafta aras\u0131nda de\u011fi\u015fir ve 6-8 hafta sonras\u0131nda ise antidepresan\u0131n tam olarak etkisini hissedersiniz.<\/p>\n\n\n\n


E\u011fer anksiyete i\u00e7in antidepresan kullanan biriyseniz, antidepresan\u0131n etkisini g\u00f6stermesi daha uzun bir s\u00fcre alacakt\u0131r.4-6 hafta sonras\u0131nda kendinizi daha iyi hissetmeye ba\u015flars\u0131n\u0131z. Antidepresan\u0131n tam etkisini hissetmeniz ise 12 haftay\u0131 bulan bir s\u00fcre\u00e7.<\/p>\n\n\n\n

<\/p>\n\n\n\n

Antidepresan ve \u0130ntihar<\/strong><\/p>\n\n\n\n

Antidepresanlar\u0131n \u015fiddete ve intihara y\u00f6nelime sebep olup olmad\u0131\u011f\u0131 hep tart\u0131\u015fma konusu olmu\u015ftur. Antidepresan kullan\u0131p intihar eden birka\u00e7 ki\u015finin haberleri t\u00fcm d\u00fcnyada yay\u0131lmaya ba\u015flad\u0131\u011f\u0131 zaman, ila\u00e7 \u015firketlerinin ger\u00e7e\u011fi herkesten saklad\u0131\u011f\u0131 iddia edildi. Fakat 2004 y\u0131l\u0131na gelene kadar g\u00f6r\u00fcyoruzki, \u00e7ocuklara ve ergenlere yaz\u0131lan antidepresan say\u0131s\u0131 olduk\u00e7a y\u00fcksek. 2004 y\u0131l\u0131nda ise FDA’n\u0131n kara kutu uyar\u0131s\u0131 \u00fczerine ergenlere ve \u00e7ocuklara verilen antidepresan say\u0131s\u0131 olduk\u00e7a azalmaya ba\u015fl\u0131yor. Bir ila\u00e7ta kara kutu uyar\u0131s\u0131n\u0131n olmas\u0131, o ilac\u0131n \u00e7ocuk ve ergenlerde intihara ve \u015fiddete y\u00f6nelime sebebiyet verebilece\u011finin g\u00f6stergesidir.<\/p>\n\n\n\n


\u0130ngiliz \u0130la\u00e7 ve Sa\u011fl\u0131k \u00dcr\u00fcnleri D\u00fczenlemesi Dairesi’nin, birtak\u0131m antidepresanlar\u0131n 18 ya\u015f alt\u0131ndakiler i\u00e7in hayati tehlike olu\u015fturdu\u011funu belirtmesi \u00fczerine American College of Neuropsychopharmacology, antidepresanlar\u0131n yan etkilerine ra\u011fmen, kullan\u0131lmad\u0131\u011f\u0131nda daha b\u00fcy\u00fck sorunlara yol a\u00e7aca\u011f\u0131n\u0131 belirtti.<\/p>\n\n\n\n


FDA antidepresanlar\u0131n ergenlerde intihar e\u011filimini art\u0131rabilece\u011fini belirtirken, ilac\u0131n \u00e7ocuklarda ve ergenlerde dikkatli kullan\u0131lmas\u0131 gerekti\u011fini s\u00f6yl\u00fcyor.<\/p>\n\n\n\n


Baz\u0131 uzmanlara g\u00f6re ise, intihar e\u011filiminin ila\u00e7 veya ilac\u0131n etkisini g\u00f6stermesi i\u00e7in ge\u00e7en zaman veya tan\u0131s\u0131 konmam\u0131\u015f bipolar bozukluktan kaynaklabilece\u011fidir.<\/p>\n\n\n\n

<\/p>\n\n\n\n

KAYNAKLAR:<\/p>\n\n\n\n

  1. https:\/\/link.springer.com\/chapter\/10.1007\/978-81-322-2803-5_26<\/li>
  2. https:\/\/www.medicalnewstoday.com\/kc\/antidepressants-work-248320<\/li>
  3. https:\/\/www.rxlist.com\/antidepressants\/drugs-condition.htm<\/li>
  4. https:\/\/dergipark.org.tr\/download\/article-file\/315255<\/li>
  5. https:\/\/www.nhs.uk\/conditions\/antidepressants\/<\/li>
  6. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK361016\/<\/li>
  7. https:\/\/www.mayoclinic.org\/diseases-conditions\/depression\/in-depth\/antidepressants\/art-20046273<\/li>
  8. https:\/\/www.nps.org.au\/consumers\/antidepressant-medicines-explained#which-antidepressant?<\/li>
  9. https:\/\/www.nps.org.au\/consumers\/antidepressant-medicines-explained#how-long-will-i-need-to-take-antidepressants?<\/li>
  10. https:\/\/time.com\/5169013\/antidepressants-more-effective-placebo-treating-depression\/<\/li>
  11. https:\/\/www.health.harvard.edu\/newsletter_article\/Antidepressants_and_suicide<\/li>
  12. https:\/\/www.e-psikiyatri.com\/antidepresanlar-intihari-tetikliyor-mu<\/li><\/ol>\n","protected":false},"excerpt":{"rendered":"

    Klinik olarak tan\u0131m\u0131 ilk kez 1950’lerde yap\u0131lan ve 1980’lerin sonuna do\u011fru t\u00fcm d\u00fcnyada yayg\u0131nla\u015fan Antidepresan, ba\u015fta “Maj\u00f6r Depresif Bozukluk” ve<\/p>\n","protected":false},"author":52,"featured_media":2610,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[343,337,385,384,342,344,350,338,125,62,143,84],"acf":[],"views":2647,"_links":{"self":[{"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/posts\/2596"}],"collection":[{"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/users\/52"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/comments?post=2596"}],"version-history":[{"count":4,"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/posts\/2596\/revisions"}],"predecessor-version":[{"id":7996,"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/posts\/2596\/revisions\/7996"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/media\/2610"}],"wp:attachment":[{"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/media?parent=2596"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/categories?post=2596"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/tags?post=2596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}